Find a Lawyer

Healthcare / Life Sciences

• Represented AB Sciex in connection with the joint venture relating toreagents R&D and production with Dian Diagnostics (300244), a China listed company
• Represented a healthcare MNC in dealing with AIC on an investigation case (ended with a satisfactory result)
• Advised Siemens Healthcare on the Shanghai proton & heavy ionproject (for cancer treatment) including contracts management, data protection,radiation issue, clinical trial and registration, claim management, interfacing issues in operation etc.
• Advised Eight Roads, an English VC fund (investing DeltaHealth Hospitalin China), on health data protection
• Advised Siemens Healthcare on legitimacy and compliance of certainproposed new business models
• Provided daily legal support to Beckman Coulter (an American IVDmanufacturer) and advised on legitimacy and compliance of promotional plans andhealth data projects
• Advised Haemonetics on regulatory compliance programs
• Provided compliance training and advisory services to United Imaging andadvised on imaging data collection and transfer issues
• Advised Ortho Clinical Diagnostics (an IVD manufacturer, a businessspin-off from Johnson & Johnson) on legitimacy and compliance of certainproposed business models
• Provided daily legal support to Danaher (an American corporation investing and managing portfolio businesses mostly in the healthcare industry)and developed model terms of distribution agreement for its business sectors in China
• Advised DeltaHealth Hospital on its daily operation and large medicaldevice procurement, and legitimacy and compliance of certain promotional plansand patient data protection
• Advised Leica Microsystems (a microscopes manufacturer) on distributionagreement and daily operation
• Advised Avellino (a Korean and US based DNA testing service provider) on establishing its DNA testing business in China (regulatory affairs, businessmodel adoption, cooperation with labs and distributors, WFOE establishment,trademark registration etc.)
• Advised Kavo-Sybron (a dental device manufacturer) on using the business model of ODM
• Advised Kavo-Kerr (a dental device manufacturer) on its Suzhou plant construction contract
• Advised RadioMeter (an acute care testing device manufacturer) on health data collection and use issues and its daily operation
• Advised HOYA (an intraocular lens manufacturer) on its distribution in China
• Advised SYSMEX on its distribution in China
• Advised an internet+ healthcare startup on its daily operation,compliance and financing
• Provided compliance training to VIVA, a subsidiary of URGO (a Frenchhealthcare group)

Transactions

• Advised a Chinese seller in selling its dispensing equipment business to Mycronic (a Sweden listed co.)
• Undertook due diligence exercise on a Hong Kong invested printingcompany on behalf of an Austrilian printing group
• Undertook due diligence exercise for 3 wastewater treatment projects onbehalf of Suez, a French water company
• Advised an Australian engineering company on the acquisition of fourengineering design companies in China
• Advised Wal-Mart on the China business restructuring and post spin offintegration in relation to the project of sale of Wal-Mart and Asda ownedproperty development company - Gazeley to a Dubai Government investment vehicle
• Advised an European company on the acquisition of a set top box businessin China, in particular on the issue of employees transfer in connection with the transaction
• Advised Ingersoll Rand on the buyout of a Chinese partner's equity interest in a joint venture
• Advised Ingersoll Rand on the local integration following the sale ofthe construction vehicle business to Volvo
• Undertook due diligence exercise on Soufun.com

Foreign Direct Investment

• Advised Ingersoll Rand on the Asia Pacific industrial campus project (inWujiang, Jiangshu Province) and China business restructuring including siteselection, terms negotiation, site acquisition, risk analysis, feasibilitystudy, structuring, company establishment, and relocation etc.
• Advised Ingersoll Rand on its dispute with a JV Chinese partner andoptions on exit from and dissolution of the JV enterprise
• Advised a Japanese infrastructure fund on overview of the water tariff and concession in China and the acquisition of a water plant in Fujian province
• Advised Sino-French on the issue of secondary water supply in China
• Advised Suez Environmental on the business model to invest in Chinesewater saving industry
• Advised BENE on close-down of its Shanghai subsidiary
• Advised SEI on its JV dispute with its Chinese partner and judicialdissolution
• Advised John Cotton, a UK textiles manufacturer, on its businesscooperation model and agreement with Chinese suppliers
• Advised Sevan, an Europe oil drilling manufacturer, on import & export issues for an offshore oil drilling platform construction project
• Advised Husky Products, a UK refrigerator supplier, on cooperationdisputes with Chinese suppliers
• Advised a stated owned property developer on financing its real estate development projects

Regulatory Requirements & Compliance

• Advised SkyScanner on ICP related issue
• Advised Stone & Webster, a US construction engineering company, on China health and safety requirements and provide strategic advice in dealing with construction accidents at nuclear plants
• Advised Mark Sensing, an Australian print and paper company onproduction license issues, also, communicate on its behalf with AQSIQ in relation to compliance issues
• Carried out due diligence exercise on Siemens’ cooperated intermediaries for compliance purpose
• Provided staff training in relation to PRC law update, code of conductand FCPA at Ingersoll Rand
• Undertook investigation on suspected violation of code of conduct for International Paper

• Bachelor, East China University of Political Science and Law

• 2012 to date Dentons Shanghai, partner
• 2011 - 2012  seconded counsel at Siemens
• 2007 - 2011  Pinsent Masons LLP, associate
• 2005 - 2007  Ingersoll Rand, regional counsel for China
• 2000 - 2005  Allen & John Law Firm, lawyer

• PRC Licensed Lawyer

• “China’s New Round of Reform of Accelerating Regulatory Approval on Medical Products” (2017)
• “Kill the Black Swans - Probably a Revolutionary Change in the Antibribery Regime in China” (2017)
• “Revenue-Based Commission - a Risk for CSO” (2017)
• “Summary of Local Policies to Implement Two-invoice System in Healthcare Industry and Our Observation” & “National Version of Two-invoice System”(2017)
• “2016 Year in Review – Penalty Counting for Medical Institutions inShanghai” (2017)
• “Penalty Counting for Pharmaceutical, Medical Device Companies and Drug Stores in Shanghai” (2017)
• “New Features Introduced by New Medical Device Recall Measures” (2017)
• “Latest Changes in China’s Administration on Internet-based Pharmaceutical Trading” (2017)
• “In-Progress Reform of China’s Approval Regime on Medical Products”(2017)
• “China’s 3-Year-Old Medial Device Regulations Changed” (2017)
• “Where is the Safe Harbour?-Preliminary Analysis of Loyalty Discounts in the Tetra Pak’s Penalty Case” published on CCH in 2016
• “What China Should Learn from GDPR on Protection of Health Data” published on CCH in 2016
• “How Foreign Investors Invest in the Chinese Genetic Diagnosis and Therapy Industries”published on CCH in 2016
• “What Healthcare Players Could Learn from the Anti-Trust Guideline for Automobile Industry (Draft for Comments)” published on CCH in 2016
• “How China Protects Personal Data Concerning Health” published on CCH in 2016
• “How Non-HongKong, Macao or Taiwan Foreign Investors Set Up a Medical Institution in theForm of WFOE in China” published on CCH in 2016
• “Red-LetterVAT Invoice A Safe Harbor for Sales Rebates” published on CCH in 2016
• ""AppleWatch, Medical Device?"" published on CCH and LexisNexisin April 2015
• ""The Implications to the Life Science Sectors of 2015 Edition Foreign Investment Industries Catalog"" publised on CCH and LexisNexis inMarch 2015
• ""The Three Misreading on China's Regulatory Requirement on Gene Testing Business"" published on LexiNexis in Jan 2015
• “Legal Research: a Lawyers' Art of Fighting Against Oneself for Better Results”published on LexiNexis in Jan 2015
• ""What Can We Benefit from the New Medical Device Regulations"" (bilingual) published on LegalSutdio in April 2014